Clinical Trials Directory

Trials / Completed

CompletedNCT04463992

Lay Health Worker Expanded Intervention in Community Oncology Practices

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
416 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
75 Years – 100 Years
Healthy volunteers
Accepted

Summary

Undertreated patient symptoms and resulting acute care use require approaches that improve symptom-burden. Previously a lay health worker (LHW)-led symptom screening intervention was developed for patients with cancer. In pilot work, the intervention was associated with improvements in patient symptom burden and reductions in healthcare use and costs of care at the end of life. This intervention will be expanded across several clinics to evaluate the impact of the LHW intervention on with cancer and the LHW will be trained to refer patients to palliative care. This randomized intervention will evaluate the effect on healthcare use, total costs, palliative care and hospice referral.

Detailed description

All patients with newly diagnosed cancer, over the age of 75 will be randomized into the CareMore Pilot 2 Program with 200 randomized to the intervention grou and 200 randomized to the control group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProgram participantsThe intervention is a 12-month telephonic program in which a lay health worker (LHW), supervised on-site by a registered nurse practitioner (RNP), assessed patient symptoms after diagnosis using the validated Edmonton Symptom The intervention is a 12-month telephonic program in which a lay health worker (LHW), supervised on-site by a registered nurse practitioner (RNP), assessed patient symptoms after diagnosis using the validated Edmonton Symptom Assessment Scale (ESAS) (cite) with the frequency of symptom assessment varying based on patient risk.
OTHERUsual CareUsual care as provided by local oncologists

Timeline

Start date
2020-10-05
Primary completion
2024-10-17
Completion
2024-10-17
First posted
2020-07-09
Last updated
2025-04-27

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04463992. Inclusion in this directory is not an endorsement.